NCT03514017 2026-03-02Ibrutinib and PD-1 Blockade in High Risk Lymphocytic LeukemiaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated5 enrolled 11 charts
NCT03246906 2025-06-04Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationFred Hutchinson Cancer CenterPhase 2 Terminated150 enrolled